Thursday Nov 10, 2022

A new hope in cachexia and an outsider’s view on pharma

In the latest installment of the pharmaphorum podcast, Editor in Chief Jonah Comstock sits down with Russell Potterfield, CEO at Endevica Pharma.

A biotech CEO who comes from the business and investment worlds, Russell now runs Endevica, which is working on a novel therapy for cachexia, a wasting syndrome that accompanies many cancers.

Comments (0)

To leave or reply to comments, please download free Podbean or

No Comments

© 2022 Pharmaphorum

Podcast Powered By Podbean

Version: 20241125